Ben Venue Laboratories, on the verge of closing months ago, getting a new owner

The Boehringer Ingelheim Group of Companies announced Thursday that it had entered into an agreement with Hikma Pharmaceuticals PLC to sell Ben Venue's facilities, site and related assets to the London-based multinational pharmaceutical company.

http://ift.tt/1pRBQmn